These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 2890116

  • 1. Modulation by enkephalin analogues and neuroleptics of apomorphine-induced stereotypy and turning behaviour in rats.
    Polgár K, Máté I, Till M, Székely JI.
    Neuropharmacology; 1987 Sep; 26(9):1309-14. PubMed ID: 2890116
    [Abstract] [Full Text] [Related]

  • 2. Modulation of dopamine-induced hypermotility following injection of various opioids into the nucleus accumbens.
    Erdö F, Polgár K, Máté I, Székely JI.
    Acta Physiol Hung; 1990 Sep; 76(3):219-27. PubMed ID: 1966032
    [Abstract] [Full Text] [Related]

  • 3. Morphine and [D-Met2,Pro5]enkephalinamide do not show specific neuroleptic activity.
    Sineger E, Horváth K, Miglécz E, Tarnawa I, Andrási F, Székely JI.
    Eur J Pharmacol; 1982 Jun 04; 80(4):359-68. PubMed ID: 6125401
    [Abstract] [Full Text] [Related]

  • 4. Dopamine-mediated behavior produced by the enkephalin analogue FK 33-824.
    Extein I, Lo C, Goodwin FK, Schoenfeld RI.
    Psychiatry Res; 1979 Dec 04; 1(3):333-9. PubMed ID: 233159
    [Abstract] [Full Text] [Related]

  • 5. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM, Elands J, Király I, Wolterink G.
    Eur J Pharmacol; 1989 Aug 03; 166(3):441-52. PubMed ID: 2572429
    [Abstract] [Full Text] [Related]

  • 6. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
    Jhamandas K, Sutak M.
    Br J Pharmacol; 1980 Aug 03; 71(1):201-10. PubMed ID: 7470736
    [Abstract] [Full Text] [Related]

  • 7. Behavioural effects of chronic treatment with apomorphine in combination with neuroleptic drugs.
    Kenny M, Leonard BE.
    J Neurosci Res; 1980 Aug 03; 5(4):291-8. PubMed ID: 6107385
    [Abstract] [Full Text] [Related]

  • 8. Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390.
    Butkerait P, Friedman E.
    Eur J Pharmacol; 1988 Mar 29; 148(2):269-72. PubMed ID: 2897925
    [Abstract] [Full Text] [Related]

  • 9. Receptor-selective opioid peptides fail to affect behavioral responses induced by a low dose of apomorphine in the mouse.
    Ukai M, Toyoshi T, Kameyama T.
    Pharmacol Biochem Behav; 1993 Nov 29; 46(3):587-91. PubMed ID: 7904071
    [Abstract] [Full Text] [Related]

  • 10. Mu and delta receptors: their role in analgesia in the differential effects of opioid peptides on analgesia.
    Vaught JL, Rothman RB, Westfall TC.
    Life Sci; 1982 Apr 26; 30(17):1443-55. PubMed ID: 6283293
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of [D-Ala2, D-Leu5]enkephalin and [D-Pen2, L-Pen5]enkephalin on apomorphine-induced motor activity in the mouse.
    Ukai M, Toyoshi T, Kameyama T.
    Pharmacol Biochem Behav; 1992 Jan 26; 41(1):171-6. PubMed ID: 1311454
    [Abstract] [Full Text] [Related]

  • 13. The effects of yohimbine and neuroleptics on apomorphine-induced pecking behaviour in the pigeon.
    Akbas O, Verimer T, Onur R, Kayaalp SO.
    Neuropharmacology; 1984 Nov 26; 23(11):1261-4. PubMed ID: 6152018
    [Abstract] [Full Text] [Related]

  • 14. Differences between antipsychotic drugs in persistence of brain levels and behavioral effects.
    Cohen BM, Tsuneizumi T, Baldessarini RJ, Campbell A, Babb SM.
    Psychopharmacology (Berl); 1992 Nov 26; 108(3):338-44. PubMed ID: 1355924
    [Abstract] [Full Text] [Related]

  • 15. Neuropeptide modulation of apomorphine-induced stereotyped behavior.
    Blumstein LK, Crawley JN, Davis LG, Baldino F.
    Brain Res; 1987 Feb 24; 404(1-2):293-300. PubMed ID: 3567572
    [Abstract] [Full Text] [Related]

  • 16. Extract of Synedrella nodiflora (L) Gaertn exhibits antipsychotic properties in murine models of psychosis.
    Amoateng P, Adjei S, Osei-Safo D, Kukuia KKE, Bekoe EO, Karikari TK, Kombian SB.
    BMC Complement Altern Med; 2017 Aug 07; 17(1):389. PubMed ID: 28784133
    [Abstract] [Full Text] [Related]

  • 17. In vivo electrochemical and behavioral evidence for specific neural substrates modulated differentially by enkephalin in rat stimulant stereotypy and locomotion.
    Broderick PA, Gardner EL, van Praag HM.
    Biol Psychiatry; 1984 Jan 07; 19(1):45-54. PubMed ID: 6538442
    [Abstract] [Full Text] [Related]

  • 18. Effects of naloxone on methamphetamine and apomorphine stereotypy and on haloperidol catalepsy in rats.
    Balsara JJ, Nandal NV, Burte NP, Jadhav JH, Chandorkar AG.
    Psychopharmacology (Berl); 1984 Jan 07; 82(3):237-40. PubMed ID: 6425907
    [Abstract] [Full Text] [Related]

  • 19. Dopamine antagonist properties of atypical neuroleptics may be revealed following mesolimbic denervation.
    Nohria V, Costall B, Naylor RJ.
    Int Pharmacopsychiatry; 1981 Jan 07; 16(1):21-9. PubMed ID: 6117535
    [Abstract] [Full Text] [Related]

  • 20. Mixed D2/5-HT2 antagonism differentially affects apomorphine- and amphetamine-induced stereotyped behavior.
    Feldman DJ, Frank RA, Kehne JH, Flannery R, Brown D, Soni S, Byrd G, Shah S.
    Pharmacol Biochem Behav; 1997 Oct 07; 58(2):565-72. PubMed ID: 9300620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.